Status:
WITHDRAWN
Small-Volume, Patient-Specific, Balanced Hypertonic Fluid Protocol Validation
Lead Sponsor:
Stanford University
Conditions:
Cerebral Edema
Saline Solution, Hypertonic
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
Many patients with traumatic brain injuries (including strokes, blood clots, or other brain injuries) are given concentrated salt water solutions (hypertonic saline) in order to treat brain swelling (...
Eligibility Criteria
Inclusion
- Able to consent
- 18 years or older
- English speaking
- Clinical indication (intracranial hypertension from cerebral edema) for hypertonic fluid administration
Exclusion
- Fails to consent
- \< 18 years old
- Hypertonic therapy not indicated
Key Trial Info
Start Date :
November 28 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2020
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03330704
Start Date
November 28 2017
End Date
January 1 2020
Last Update
March 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University Hospital
Stanford, California, United States, 94305